Companies: 10,795·Total market cap: $144.5T

Mithra Pharmaceuticals S.A.

Mithra Pharmaceuticals S.A.

MITPFOTCHealthcare

$23.90

+$17.15(+254.07%)

Market Cap$1.6B

P/E Ratio—

52W High$23.9

52W Low$6.75

Avg Volume285.34673

Open$6.75

Beta0.60

Mithra Pharmaceuticals S.A. (MITPF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MITPF · net income · updated Jun 9, 2026

Core profitability metrics

MITPF · net income · margin · TTM · CAGR

Net income was −$173.5M for FY2023 (fiscal year ending 2023-12-31), down 191.0% year-over-year. Net profit margin was -432.1%.

FY2023 Net Income−$173.5M▼ -191.0% YoY

Trailing 12M (TTM)−$233.1Mtrailing 4 quarters sum

Net Profit Margin-432.1%−$173.5M ÷ $40.2M

YoY Change-191.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · MITPF net income history · MITPF profit margin

Annual net income data

MITPF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2023Loss−$173.5M▼ 191.0%-432.1%$40.2M

FY2022Loss−$59.6M▲ +49.0%-89.0%$67.0M

FY2021Loss−$116.9M▼ 26.9%-515.6%$22.7M

FY2020Loss−$92.1M▼ 246.7%-1019.8%$9.0M

FY2019Loss−$26.6M▲ +3.8%-27.5%$96.5M

Net income vs peers (Healthcare)

MITPF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Mithra Pharmaceuticals S.A.YOU

MITPF

−$173.5M-191.0%-432.1%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Mithra Pharmaceuticals S.A. (MITPF) reported net income of −$173.5M for FY2023 (fiscal year ending 2023-12-31), down 191.0% year-over-year. The net profit margin was -432.1% — meaning the company kept $-4.32 of every dollar of revenue as profit.

Mithra Pharmaceuticals S.A. has not yet achieved annual profitability based on available data (12 fiscal years). The company has reported net losses across all available periods.

Mithra Pharmaceuticals S.A.'s net profit margin was -432.1% for FY2023, based on the latest annual results.

Investors sometimes search for "Mithra Pharmaceuticals S.A. net worth" — the company's market capitalization is a separate figure from MITPF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MITPF net income · 4 questions

Mithra Pharmaceuticals S.A. is not currently profitable on an annual basis. The company reported a net loss of $173.5M for FY2023.

is MITPF profitabledoes MITPF make a profitMITPF profitabilityMITPF profitable company

▸ Source: FMP /income-statement · GAAP · Mithra Pharmaceuticals S.A. · Mithra Pharmaceuticals S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026